Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tomonari Hosokawa
Institution:
Zikei Institute of Psychiatry
Observed institutions:
Okayama University,
Zikei Institute of Psychiatry
ORCID:
0009-0006-0197-3746
Observed ORCID:
0009-0006-0197-3746
OpenAlex ID:
A5082797625
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta‐analysis
2024
·
Kazumasa Kotake
, Tomonari Hosokawa
, et al.
·
Addiction
·
22
Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting System
2023
·
Kazumasa Kotake
, Satoru Mitsuboshi
, et al.
·
Schizophrenia Research
·
1
Comparison between olanzapine and aripiprazole treatment for 104 weeks after hospital discharge in schizophrenia spectrum disorders: a multicenter retrospective cohort study in a real-world setting
2023
·
Tomonari Hosokawa
, Chikara Miyaji
, et al.
·
Psychopharmacology
PDF
Efficacy and safety of drug therapy aimed at reducing alcohol consumption in the treatment of alcohol dependence or alcohol use disorders: a systematic review and network meta-analysis v1
2021
·
Kazumasa Kotake
, Tomonari Hosokawa
, et al.
Efficacy and safety of drug therapy aimed at reducing alcohol consumption in the treatment of alcohol dependence or alcohol use disorders: a systematic review and network meta-analysis v1
2021
·
Kazumasa Kotake
, Tomonari Hosokawa
, et al.
Show more works
View as search
Works count:
5
Citation count:
23
H-index:
1
I10-index:
1
Year
Topic
Type